Endologix Acquires Nellix for $54,000,000
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ff8a7b66-9202-4403-ae4b-d81ace17c7ef&Preview=1 - Date
10/27/2010 - Company Name
Nellix - Mailing Address
2465-B Faber Place Palo Alto, CA 94303 - Company Description
Nellix has developed a revolutionary, percutaneously deliverable endograft for the treatment of Abdominal Aortic Aneurysms and Thoracic Aortic Aneurysms. This aortic endograft device and treatment fills the aneurysm, providing a highly stable and durable seal. The novel technology enables treatment of all aortic aneurysms and provides a distinct advantage over current therapies. - Website
http://www.nellix.com - Transaction Type
M&A - Transaction Amount
$54,000,000 - Transaction Round
- Proceeds Purposes
- M&A Terms
Endologix has acquired venture-backed medical device company Nellix Endovascular for $15 million in stock, plus additional milestone-based stock payments totaling as much as $39 million. As part of the acquisition, Nellix’s majority investor, Essex Woodlands Health Ventures, will also invest $15 million in the newly combined company.
